4//SEC Filing
Karas Kevin R 4
Accession 0001567619-21-006960
CIK 0000070487other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 4:36 PM ET
Size
15.2 KB
Accession
0001567619-21-006960
Insider Transaction Report
Form 4
Karas Kevin R
SVP Finance, CFO, Treas & Secy
Transactions
- Exercise/Conversion
Common Stock
2021-03-23$18.80/sh+5,334$100,279→ 15,718 total - Exercise/Conversion
Common Stock
2021-03-23$13.17/sh+19,313$254,352→ 35,031 total - Tax Payment
Common Stock
2021-03-23$45.55/sh−12,735$580,079→ 22,296 total - Sale
Common Stock
2018-09-24$38.23/sh−3,700$141,446→ 10,684 total - Sale
Common Stock
2018-09-24$39.06/sh−300$11,717→ 10,384 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-03-23−5,334→ 0 totalExercise: $18.80Exp: 2024-01-07→ Common Stock (5,334 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-03-23−19,313→ 0 totalExercise: $13.17Exp: 2025-01-06→ Common Stock (19,313 underlying)
Footnotes (4)
- [F1]The price in Column 4 is a weighted average. The prices actually ranged from $38.00 to $38.70, inclusive. The reporting person has provided the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4.
- [F2]The price in Column 4 is a weighted average price. The prices actually ranged from $39.025 to $39.075, inclusive.
- [F3]This option became fully exercisable on January 7, 2019.
- [F4]This option became fully exercisable on January 6, 2020.
Documents
Issuer
NATIONAL RESEARCH CORP
CIK 0000070487
Entity typeother
Related Parties
1- filerCIK 0001522907
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 4:36 PM ET
- Size
- 15.2 KB